nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—ABCB1—colon cancer	0.243	1	CbGaD
Lovastatin—UGT1A1—Irinotecan—colon cancer	0.0719	0.133	CbGbCtD
Lovastatin—SLCO1B1—Irinotecan—colon cancer	0.0498	0.0922	CbGbCtD
Lovastatin—ABCC2—Irinotecan—colon cancer	0.0437	0.081	CbGbCtD
Lovastatin—ABCC2—Vincristine—colon cancer	0.0382	0.0708	CbGbCtD
Lovastatin—CYP3A7—Irinotecan—colon cancer	0.0292	0.0541	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Irinotecan—colon cancer	0.0292	0.0541	CbGbCtD
Lovastatin—SLCO1A2—Methotrexate—colon cancer	0.0279	0.0517	CbGbCtD
Lovastatin—SLCO1B1—Methotrexate—colon cancer	0.0263	0.0488	CbGbCtD
Lovastatin—CYP3A7—Vincristine—colon cancer	0.0255	0.0473	CbGbCtD
Lovastatin—CYP3A7-CYP3A51P—Vincristine—colon cancer	0.0255	0.0473	CbGbCtD
Lovastatin—CYP2C9—Capecitabine—colon cancer	0.0238	0.0441	CbGbCtD
Lovastatin—ABCC2—Methotrexate—colon cancer	0.0232	0.0429	CbGbCtD
Lovastatin—CYP3A5—Irinotecan—colon cancer	0.0219	0.0406	CbGbCtD
Lovastatin—CYP2C8—Fluorouracil—colon cancer	0.0202	0.0374	CbGbCtD
Lovastatin—CYP3A5—Vincristine—colon cancer	0.0192	0.0355	CbGbCtD
Lovastatin—ABCB1—Irinotecan—colon cancer	0.0143	0.0264	CbGbCtD
Lovastatin—CYP2C9—Fluorouracil—colon cancer	0.0141	0.0261	CbGbCtD
Lovastatin—ABCB1—Vincristine—colon cancer	0.0125	0.0231	CbGbCtD
Lovastatin—CYP3A4—Irinotecan—colon cancer	0.00854	0.0158	CbGbCtD
Lovastatin—ABCB1—Methotrexate—colon cancer	0.00755	0.014	CbGbCtD
Lovastatin—CYP3A4—Vincristine—colon cancer	0.00747	0.0138	CbGbCtD
Lovastatin—ITGAL—endothelium—colon cancer	0.00635	0.0791	CbGeAlD
Lovastatin—ITGAL—blood vessel—colon cancer	0.00586	0.0729	CbGeAlD
Lovastatin—ABCC2—bile—colon cancer	0.0052	0.0648	CbGeAlD
Lovastatin—HDAC2—Topotecan—Irinotecan—colon cancer	0.00335	1	CbGdCrCtD
Lovastatin—ITGAL—epithelium—colon cancer	0.00285	0.0355	CbGeAlD
Lovastatin—Memory loss—Fluorouracil—colon cancer	0.00255	0.0354	CcSEcCtD
Lovastatin—ITGAL—lymphoid tissue—colon cancer	0.0022	0.0273	CbGeAlD
Lovastatin—ITGAL—digestive system—colon cancer	0.00217	0.027	CbGeAlD
Lovastatin—ITGAL—bone marrow—colon cancer	0.002	0.0249	CbGeAlD
Lovastatin—HMGCR—gall bladder—colon cancer	0.00199	0.0248	CbGeAlD
Lovastatin—PON3—bone marrow—colon cancer	0.00196	0.0244	CbGeAlD
Lovastatin—VIIth nerve paralysis—Vincristine—colon cancer	0.00196	0.0272	CcSEcCtD
Lovastatin—ITGAL—vagina—colon cancer	0.00192	0.0239	CbGeAlD
Lovastatin—PON3—vagina—colon cancer	0.00188	0.0234	CbGeAlD
Lovastatin—UGT1A3—digestive system—colon cancer	0.00185	0.023	CbGeAlD
Lovastatin—ITGAL—liver—colon cancer	0.00162	0.0201	CbGeAlD
Lovastatin—PON3—liver—colon cancer	0.00159	0.0197	CbGeAlD
Lovastatin—Cognitive impairment—Methotrexate—colon cancer	0.00149	0.0207	CcSEcCtD
Lovastatin—HDAC2—embryo—colon cancer	0.0014	0.0174	CbGeAlD
Lovastatin—UGT1A3—liver—colon cancer	0.00137	0.0171	CbGeAlD
Lovastatin—Nodule—Methotrexate—colon cancer	0.00132	0.0184	CcSEcCtD
Lovastatin—UGT2B7—renal system—colon cancer	0.00129	0.0161	CbGeAlD
Lovastatin—VIIth nerve paralysis—Capecitabine—colon cancer	0.00127	0.0177	CcSEcCtD
Lovastatin—ITGAL—lymph node—colon cancer	0.00124	0.0154	CbGeAlD
Lovastatin—HDAC2—epithelium—colon cancer	0.00114	0.0142	CbGeAlD
Lovastatin—UGT1A1—renal system—colon cancer	0.0011	0.0137	CbGeAlD
Lovastatin—HDAC2—smooth muscle tissue—colon cancer	0.0011	0.0137	CbGeAlD
Lovastatin—UGT2B7—digestive system—colon cancer	0.00106	0.0132	CbGeAlD
Lovastatin—HDAC2—renal system—colon cancer	0.00106	0.0132	CbGeAlD
Lovastatin—Simvastatin—ABCB1—colon cancer	0.00105	0.506	CrCbGaD
Lovastatin—HMGCR—epithelium—colon cancer	0.00103	0.0128	CbGeAlD
Lovastatin—Pravastatin—ABCB1—colon cancer	0.00102	0.495	CrCbGaD
Lovastatin—HMGCR—smooth muscle tissue—colon cancer	0.000991	0.0123	CbGeAlD
Lovastatin—HMGCR—renal system—colon cancer	0.000954	0.0119	CbGeAlD
Lovastatin—SLCO1B1—renal system—colon cancer	0.000914	0.0114	CbGeAlD
Lovastatin—UGT1A1—digestive system—colon cancer	0.000901	0.0112	CbGeAlD
Lovastatin—Cognitive disorder—Methotrexate—colon cancer	0.0009	0.0125	CcSEcCtD
Lovastatin—Accidental injury—Irinotecan—colon cancer	0.000883	0.0123	CcSEcCtD
Lovastatin—HDAC2—lymphoid tissue—colon cancer	0.000878	0.0109	CbGeAlD
Lovastatin—Eye irritation—Fluorouracil—colon cancer	0.000876	0.0122	CcSEcCtD
Lovastatin—HDAC2—digestive system—colon cancer	0.000867	0.0108	CbGeAlD
Lovastatin—Tenderness—Fluorouracil—colon cancer	0.000858	0.0119	CcSEcCtD
Lovastatin—Loss of libido—Methotrexate—colon cancer	0.000843	0.0117	CcSEcCtD
Lovastatin—CYP3A7—liver—colon cancer	0.000815	0.0101	CbGeAlD
Lovastatin—Musculoskeletal pain—Vincristine—colon cancer	0.000812	0.0113	CcSEcCtD
Lovastatin—HDAC2—bone marrow—colon cancer	0.0008	0.00995	CbGeAlD
Lovastatin—HMGCR—lymphoid tissue—colon cancer	0.000792	0.00986	CbGeAlD
Lovastatin—UGT2B7—liver—colon cancer	0.00079	0.00983	CbGeAlD
Lovastatin—HMGCR—digestive system—colon cancer	0.000783	0.00974	CbGeAlD
Lovastatin—Phosphatase alkaline increased—Irinotecan—colon cancer	0.000781	0.0109	CcSEcCtD
Lovastatin—HDAC2—vagina—colon cancer	0.000766	0.00954	CbGeAlD
Lovastatin—SLCO1B1—digestive system—colon cancer	0.00075	0.00933	CbGeAlD
Lovastatin—SLCO1A2—renal system—colon cancer	0.000744	0.00926	CbGeAlD
Lovastatin—HMGCR—bone marrow—colon cancer	0.000722	0.00898	CbGeAlD
Lovastatin—ABCC2—renal system—colon cancer	0.000693	0.00863	CbGeAlD
Lovastatin—CYP3A7-CYP3A51P—liver—colon cancer	0.000693	0.00862	CbGeAlD
Lovastatin—HMGCR—vagina—colon cancer	0.000691	0.0086	CbGeAlD
Lovastatin—UGT1A1—liver—colon cancer	0.000671	0.00836	CbGeAlD
Lovastatin—Memory impairment—Capecitabine—colon cancer	0.000666	0.00926	CcSEcCtD
Lovastatin—Blood alkaline phosphatase increased—Irinotecan—colon cancer	0.000652	0.00906	CcSEcCtD
Lovastatin—Hepatic failure—Vincristine—colon cancer	0.000648	0.00901	CcSEcCtD
Lovastatin—HDAC2—liver—colon cancer	0.000646	0.00804	CbGeAlD
Lovastatin—Photosensitivity—Fluorouracil—colon cancer	0.000619	0.0086	CcSEcCtD
Lovastatin—Injury—Irinotecan—colon cancer	0.000617	0.00858	CcSEcCtD
Lovastatin—Eye irritation—Capecitabine—colon cancer	0.000612	0.00851	CcSEcCtD
Lovastatin—SLCO1A2—digestive system—colon cancer	0.00061	0.0076	CbGeAlD
Lovastatin—HMGCR—liver—colon cancer	0.000583	0.00726	CbGeAlD
Lovastatin—Pain in extremity—Vincristine—colon cancer	0.000582	0.00809	CcSEcCtD
Lovastatin—Amnesia—Fluorouracil—colon cancer	0.000578	0.00804	CcSEcCtD
Lovastatin—ABCC2—digestive system—colon cancer	0.000568	0.00708	CbGeAlD
Lovastatin—SLCO1B1—liver—colon cancer	0.000559	0.00695	CbGeAlD
Lovastatin—ABCB1—blood vessel—colon cancer	0.000552	0.00687	CbGeAlD
Lovastatin—Cataract—Capecitabine—colon cancer	0.000549	0.00763	CcSEcCtD
Lovastatin—Phosphatase alkaline increased—Capecitabine—colon cancer	0.000523	0.00727	CcSEcCtD
Lovastatin—CYP2C8—renal system—colon cancer	0.00052	0.00647	CbGeAlD
Lovastatin—Cramp muscle—Irinotecan—colon cancer	0.000511	0.0071	CcSEcCtD
Lovastatin—HDAC2—lymph node—colon cancer	0.000495	0.00617	CbGeAlD
Lovastatin—CYP2C19—digestive system—colon cancer	0.000489	0.00608	CbGeAlD
Lovastatin—Pancreatitis—Irinotecan—colon cancer	0.000481	0.00668	CcSEcCtD
Lovastatin—CYP3A5—renal system—colon cancer	0.000469	0.00584	CbGeAlD
Lovastatin—Eosinophilia—Fluorouracil—colon cancer	0.000465	0.00646	CcSEcCtD
Lovastatin—Erectile dysfunction—Vincristine—colon cancer	0.000464	0.00644	CcSEcCtD
Lovastatin—Photosensitivity reaction—Vincristine—colon cancer	0.000459	0.00639	CcSEcCtD
Lovastatin—SLCO1A2—liver—colon cancer	0.000455	0.00566	CbGeAlD
Lovastatin—HMGCR—lymph node—colon cancer	0.000447	0.00557	CbGeAlD
Lovastatin—Neuropathy peripheral—Vincristine—colon cancer	0.00044	0.00611	CcSEcCtD
Lovastatin—Blood alkaline phosphatase increased—Capecitabine—colon cancer	0.000436	0.00607	CcSEcCtD
Lovastatin—Hepatic function abnormal—Capecitabine—colon cancer	0.000434	0.00604	CcSEcCtD
Lovastatin—Photosensitivity—Capecitabine—colon cancer	0.000432	0.00601	CcSEcCtD
Lovastatin—CYP2C19—vagina—colon cancer	0.000431	0.00537	CbGeAlD
Lovastatin—Photosensitivity reaction—Fluorouracil—colon cancer	0.000429	0.00596	CcSEcCtD
Lovastatin—Vascular purpura—Capecitabine—colon cancer	0.000424	0.0059	CcSEcCtD
Lovastatin—ABCC2—liver—colon cancer	0.000424	0.00527	CbGeAlD
Lovastatin—Hepatic failure—Capecitabine—colon cancer	0.000422	0.00587	CcSEcCtD
Lovastatin—Haemolytic anaemia—Capecitabine—colon cancer	0.00042	0.00584	CcSEcCtD
Lovastatin—Neuropathy peripheral—Fluorouracil—colon cancer	0.00041	0.0057	CcSEcCtD
Lovastatin—Urinary tract infection—Fluorouracil—colon cancer	0.000407	0.00565	CcSEcCtD
Lovastatin—Amnesia—Capecitabine—colon cancer	0.000404	0.00562	CcSEcCtD
Lovastatin—Vasculitis—Methotrexate—colon cancer	0.000399	0.00554	CcSEcCtD
Lovastatin—Purpura—Capecitabine—colon cancer	0.000394	0.00547	CcSEcCtD
Lovastatin—Sinusitis—Fluorouracil—colon cancer	0.000393	0.00546	CcSEcCtD
Lovastatin—Arthritis—Capecitabine—colon cancer	0.000391	0.00543	CcSEcCtD
Lovastatin—CYP3A5—digestive system—colon cancer	0.000385	0.00479	CbGeAlD
Lovastatin—Pain in extremity—Capecitabine—colon cancer	0.00038	0.00528	CcSEcCtD
Lovastatin—CYP2C9—digestive system—colon cancer	0.000379	0.00471	CbGeAlD
Lovastatin—CYP2C8—vagina—colon cancer	0.000377	0.00469	CbGeAlD
Lovastatin—Flushing—Irinotecan—colon cancer	0.000364	0.00506	CcSEcCtD
Lovastatin—CYP2C19—liver—colon cancer	0.000364	0.00453	CbGeAlD
Lovastatin—Alopecia—Vincristine—colon cancer	0.000356	0.00495	CcSEcCtD
Lovastatin—CYP3A4—renal system—colon cancer	0.000352	0.00438	CbGeAlD
Lovastatin—Chills—Irinotecan—colon cancer	0.000352	0.00489	CcSEcCtD
Lovastatin—Gynaecomastia—Methotrexate—colon cancer	0.000348	0.00484	CcSEcCtD
Lovastatin—Alopecia—Irinotecan—colon cancer	0.000347	0.00482	CcSEcCtD
Lovastatin—CYP2D6—renal system—colon cancer	0.000346	0.00431	CbGeAlD
Lovastatin—Toxic epidermal necrolysis—Capecitabine—colon cancer	0.000342	0.00475	CcSEcCtD
Lovastatin—CYP3A5—vagina—colon cancer	0.00034	0.00423	CbGeAlD
Lovastatin—Back pain—Vincristine—colon cancer	0.000339	0.00471	CcSEcCtD
Lovastatin—Flatulence—Irinotecan—colon cancer	0.000337	0.00468	CcSEcCtD
Lovastatin—Alopecia—Fluorouracil—colon cancer	0.000332	0.00462	CcSEcCtD
Lovastatin—Back pain—Irinotecan—colon cancer	0.00033	0.00459	CcSEcCtD
Lovastatin—ABCB1—embryo—colon cancer	0.000329	0.0041	CbGeAlD
Lovastatin—Muscle spasms—Irinotecan—colon cancer	0.000328	0.00456	CcSEcCtD
Lovastatin—Influenza—Capecitabine—colon cancer	0.000328	0.00456	CcSEcCtD
Lovastatin—ABCC2—lymph node—colon cancer	0.000325	0.00404	CbGeAlD
Lovastatin—Photosensitivity—Methotrexate—colon cancer	0.000322	0.00447	CcSEcCtD
Lovastatin—CYP2C8—liver—colon cancer	0.000318	0.00395	CbGeAlD
Lovastatin—Ill-defined disorder—Irinotecan—colon cancer	0.000317	0.0044	CcSEcCtD
Lovastatin—Vertigo—Vincristine—colon cancer	0.000315	0.00438	CcSEcCtD
Lovastatin—Abdominal discomfort—Capecitabine—colon cancer	0.000315	0.00437	CcSEcCtD
Lovastatin—Hepatic failure—Methotrexate—colon cancer	0.000314	0.00437	CcSEcCtD
Lovastatin—Leukopenia—Vincristine—colon cancer	0.000314	0.00436	CcSEcCtD
Lovastatin—Vision blurred—Fluorouracil—colon cancer	0.000308	0.00428	CcSEcCtD
Lovastatin—Malaise—Irinotecan—colon cancer	0.000308	0.00428	CcSEcCtD
Lovastatin—Vertigo—Irinotecan—colon cancer	0.000307	0.00426	CcSEcCtD
Lovastatin—Leukopenia—Irinotecan—colon cancer	0.000306	0.00425	CcSEcCtD
Lovastatin—Photosensitivity reaction—Capecitabine—colon cancer	0.000299	0.00416	CcSEcCtD
Lovastatin—Myalgia—Vincristine—colon cancer	0.000299	0.00415	CcSEcCtD
Lovastatin—Leukopenia—Fluorouracil—colon cancer	0.000293	0.00407	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.00029	0.00403	CcSEcCtD
Lovastatin—CYP3A4—digestive system—colon cancer	0.000289	0.00359	CbGeAlD
Lovastatin—Discomfort—Irinotecan—colon cancer	0.000287	0.00399	CcSEcCtD
Lovastatin—Neuropathy peripheral—Capecitabine—colon cancer	0.000287	0.00399	CcSEcCtD
Lovastatin—CYP3A5—liver—colon cancer	0.000287	0.00357	CbGeAlD
Lovastatin—Anaphylactic shock—Vincristine—colon cancer	0.000286	0.00398	CcSEcCtD
Lovastatin—Infection—Vincristine—colon cancer	0.000284	0.00395	CcSEcCtD
Lovastatin—Urinary tract infection—Capecitabine—colon cancer	0.000284	0.00395	CcSEcCtD
Lovastatin—CYP2D6—digestive system—colon cancer	0.000284	0.00354	CbGeAlD
Lovastatin—CYP2C9—liver—colon cancer	0.000282	0.00351	CbGeAlD
Lovastatin—Confusional state—Irinotecan—colon cancer	0.000281	0.00391	CcSEcCtD
Lovastatin—Thrombocytopenia—Vincristine—colon cancer	0.00028	0.00389	CcSEcCtD
Lovastatin—Anaphylactic shock—Irinotecan—colon cancer	0.000279	0.00387	CcSEcCtD
Lovastatin—Chest pain—Fluorouracil—colon cancer	0.000279	0.00387	CcSEcCtD
Lovastatin—Myalgia—Fluorouracil—colon cancer	0.000279	0.00387	CcSEcCtD
Lovastatin—Infection—Irinotecan—colon cancer	0.000277	0.00385	CcSEcCtD
Lovastatin—Discomfort—Fluorouracil—colon cancer	0.000275	0.00382	CcSEcCtD
Lovastatin—Thrombocytopenia—Irinotecan—colon cancer	0.000273	0.00379	CcSEcCtD
Lovastatin—Anorexia—Vincristine—colon cancer	0.000273	0.00379	CcSEcCtD
Lovastatin—Confusional state—Fluorouracil—colon cancer	0.000269	0.00374	CcSEcCtD
Lovastatin—ABCB1—epithelium—colon cancer	0.000269	0.00334	CbGeAlD
Lovastatin—Anaphylactic shock—Fluorouracil—colon cancer	0.000267	0.00371	CcSEcCtD
Lovastatin—Anorexia—Irinotecan—colon cancer	0.000266	0.00369	CcSEcCtD
Lovastatin—Infection—Fluorouracil—colon cancer	0.000265	0.00369	CcSEcCtD
Lovastatin—Hepatitis—Capecitabine—colon cancer	0.000263	0.00365	CcSEcCtD
Lovastatin—Thrombocytopenia—Fluorouracil—colon cancer	0.000261	0.00363	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Vincristine—colon cancer	0.000261	0.00362	CcSEcCtD
Lovastatin—Insomnia—Vincristine—colon cancer	0.000259	0.0036	CcSEcCtD
Lovastatin—Paraesthesia—Vincristine—colon cancer	0.000257	0.00357	CcSEcCtD
Lovastatin—Anorexia—Fluorouracil—colon cancer	0.000254	0.00354	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000254	0.00354	CcSEcCtD
Lovastatin—Insomnia—Irinotecan—colon cancer	0.000252	0.0035	CcSEcCtD
Lovastatin—Paraesthesia—Irinotecan—colon cancer	0.00025	0.00348	CcSEcCtD
Lovastatin—ABCB1—renal system—colon cancer	0.000249	0.0031	CbGeAlD
Lovastatin—Decreased appetite—Vincristine—colon cancer	0.000249	0.00346	CcSEcCtD
Lovastatin—Dyspnoea—Irinotecan—colon cancer	0.000249	0.00345	CcSEcCtD
Lovastatin—Erythema multiforme—Capecitabine—colon cancer	0.000248	0.00345	CcSEcCtD
Lovastatin—Fatigue—Vincristine—colon cancer	0.000247	0.00343	CcSEcCtD
Lovastatin—Dyspepsia—Irinotecan—colon cancer	0.000245	0.00341	CcSEcCtD
Lovastatin—Constipation—Vincristine—colon cancer	0.000245	0.0034	CcSEcCtD
Lovastatin—Pain—Vincristine—colon cancer	0.000245	0.0034	CcSEcCtD
Lovastatin—Flushing—Capecitabine—colon cancer	0.000244	0.00339	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000243	0.00338	CcSEcCtD
Lovastatin—Decreased appetite—Irinotecan—colon cancer	0.000242	0.00337	CcSEcCtD
Lovastatin—Eosinophilia—Methotrexate—colon cancer	0.000242	0.00336	CcSEcCtD
Lovastatin—Insomnia—Fluorouracil—colon cancer	0.000241	0.00336	CcSEcCtD
Lovastatin—Fatigue—Irinotecan—colon cancer	0.00024	0.00334	CcSEcCtD
Lovastatin—Paraesthesia—Fluorouracil—colon cancer	0.00024	0.00333	CcSEcCtD
Lovastatin—Pancreatitis—Methotrexate—colon cancer	0.000239	0.00333	CcSEcCtD
Lovastatin—Constipation—Irinotecan—colon cancer	0.000238	0.00331	CcSEcCtD
Lovastatin—Pain—Irinotecan—colon cancer	0.000238	0.00331	CcSEcCtD
Lovastatin—Dyspnoea—Fluorouracil—colon cancer	0.000238	0.00331	CcSEcCtD
Lovastatin—Chills—Capecitabine—colon cancer	0.000236	0.00327	CcSEcCtD
Lovastatin—Dyspepsia—Fluorouracil—colon cancer	0.000235	0.00327	CcSEcCtD
Lovastatin—Abdominal discomfort—Methotrexate—colon cancer	0.000234	0.00325	CcSEcCtD
Lovastatin—Gastrointestinal pain—Vincristine—colon cancer	0.000234	0.00325	CcSEcCtD
Lovastatin—Decreased appetite—Fluorouracil—colon cancer	0.000232	0.00323	CcSEcCtD
Lovastatin—Alopecia—Capecitabine—colon cancer	0.000232	0.00322	CcSEcCtD
Lovastatin—Feeling abnormal—Irinotecan—colon cancer	0.00023	0.00319	CcSEcCtD
Lovastatin—Pain—Fluorouracil—colon cancer	0.000228	0.00317	CcSEcCtD
Lovastatin—Gastrointestinal pain—Irinotecan—colon cancer	0.000228	0.00317	CcSEcCtD
Lovastatin—Abdominal pain—Vincristine—colon cancer	0.000226	0.00314	CcSEcCtD
Lovastatin—Body temperature increased—Vincristine—colon cancer	0.000226	0.00314	CcSEcCtD
Lovastatin—Flatulence—Capecitabine—colon cancer	0.000225	0.00313	CcSEcCtD
Lovastatin—Erectile dysfunction—Methotrexate—colon cancer	0.000225	0.00313	CcSEcCtD
Lovastatin—Dysgeusia—Capecitabine—colon cancer	0.000224	0.00311	CcSEcCtD
Lovastatin—Photosensitivity reaction—Methotrexate—colon cancer	0.000223	0.0031	CcSEcCtD
Lovastatin—Back pain—Capecitabine—colon cancer	0.000221	0.00307	CcSEcCtD
Lovastatin—Body temperature increased—Irinotecan—colon cancer	0.00022	0.00306	CcSEcCtD
Lovastatin—Abdominal pain—Irinotecan—colon cancer	0.00022	0.00306	CcSEcCtD
Lovastatin—Feeling abnormal—Fluorouracil—colon cancer	0.00022	0.00306	CcSEcCtD
Lovastatin—Muscle spasms—Capecitabine—colon cancer	0.00022	0.00305	CcSEcCtD
Lovastatin—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000216	0.003	CcSEcCtD
Lovastatin—Vision blurred—Capecitabine—colon cancer	0.000215	0.00299	CcSEcCtD
Lovastatin—CYP3A4—liver—colon cancer	0.000215	0.00268	CbGeAlD
Lovastatin—Tremor—Capecitabine—colon cancer	0.000214	0.00298	CcSEcCtD
Lovastatin—Ill-defined disorder—Capecitabine—colon cancer	0.000212	0.00295	CcSEcCtD
Lovastatin—Urticaria—Fluorouracil—colon cancer	0.000212	0.00295	CcSEcCtD
Lovastatin—CYP2D6—liver—colon cancer	0.000212	0.00264	CbGeAlD
Lovastatin—Body temperature increased—Fluorouracil—colon cancer	0.000211	0.00293	CcSEcCtD
Lovastatin—Hypersensitivity—Vincristine—colon cancer	0.000211	0.00293	CcSEcCtD
Lovastatin—ABCB1—lymphoid tissue—colon cancer	0.000207	0.00258	CbGeAlD
Lovastatin—Malaise—Capecitabine—colon cancer	0.000206	0.00286	CcSEcCtD
Lovastatin—Vertigo—Capecitabine—colon cancer	0.000205	0.00285	CcSEcCtD
Lovastatin—Hypersensitivity—Irinotecan—colon cancer	0.000205	0.00285	CcSEcCtD
Lovastatin—Asthenia—Vincristine—colon cancer	0.000205	0.00285	CcSEcCtD
Lovastatin—Leukopenia—Capecitabine—colon cancer	0.000205	0.00284	CcSEcCtD
Lovastatin—ABCB1—digestive system—colon cancer	0.000204	0.00254	CbGeAlD
Lovastatin—Asthenia—Irinotecan—colon cancer	0.0002	0.00278	CcSEcCtD
Lovastatin—Hypersensitivity—Fluorouracil—colon cancer	0.000197	0.00273	CcSEcCtD
Lovastatin—Diarrhoea—Vincristine—colon cancer	0.000196	0.00272	CcSEcCtD
Lovastatin—Hepatitis—Methotrexate—colon cancer	0.000195	0.00272	CcSEcCtD
Lovastatin—Myalgia—Capecitabine—colon cancer	0.000195	0.0027	CcSEcCtD
Lovastatin—Chest pain—Capecitabine—colon cancer	0.000195	0.0027	CcSEcCtD
Lovastatin—Arthralgia—Capecitabine—colon cancer	0.000195	0.0027	CcSEcCtD
Lovastatin—Anxiety—Capecitabine—colon cancer	0.000194	0.0027	CcSEcCtD
Lovastatin—Discomfort—Capecitabine—colon cancer	0.000192	0.00267	CcSEcCtD
Lovastatin—Diarrhoea—Irinotecan—colon cancer	0.000191	0.00265	CcSEcCtD
Lovastatin—Dry mouth—Capecitabine—colon cancer	0.00019	0.00265	CcSEcCtD
Lovastatin—Dizziness—Vincristine—colon cancer	0.000189	0.00263	CcSEcCtD
Lovastatin—Pruritus—Fluorouracil—colon cancer	0.000189	0.00263	CcSEcCtD
Lovastatin—ABCB1—bone marrow—colon cancer	0.000188	0.00235	CbGeAlD
Lovastatin—Confusional state—Capecitabine—colon cancer	0.000188	0.00261	CcSEcCtD
Lovastatin—Infection—Capecitabine—colon cancer	0.000185	0.00258	CcSEcCtD
Lovastatin—Erythema multiforme—Methotrexate—colon cancer	0.000185	0.00257	CcSEcCtD
Lovastatin—Dizziness—Irinotecan—colon cancer	0.000184	0.00256	CcSEcCtD
Lovastatin—Diarrhoea—Fluorouracil—colon cancer	0.000183	0.00254	CcSEcCtD
Lovastatin—Thrombocytopenia—Capecitabine—colon cancer	0.000183	0.00254	CcSEcCtD
Lovastatin—Vomiting—Vincristine—colon cancer	0.000182	0.00253	CcSEcCtD
Lovastatin—ABCB1—vagina—colon cancer	0.000181	0.00225	CbGeAlD
Lovastatin—Rash—Vincristine—colon cancer	0.00018	0.00251	CcSEcCtD
Lovastatin—Dermatitis—Vincristine—colon cancer	0.00018	0.00251	CcSEcCtD
Lovastatin—Headache—Vincristine—colon cancer	0.000179	0.00249	CcSEcCtD
Lovastatin—Anorexia—Capecitabine—colon cancer	0.000178	0.00247	CcSEcCtD
Lovastatin—Vomiting—Irinotecan—colon cancer	0.000177	0.00246	CcSEcCtD
Lovastatin—Dizziness—Fluorouracil—colon cancer	0.000177	0.00245	CcSEcCtD
Lovastatin—Rash—Irinotecan—colon cancer	0.000176	0.00244	CcSEcCtD
Lovastatin—Dermatitis—Irinotecan—colon cancer	0.000176	0.00244	CcSEcCtD
Lovastatin—Chills—Methotrexate—colon cancer	0.000175	0.00244	CcSEcCtD
Lovastatin—Headache—Irinotecan—colon cancer	0.000175	0.00243	CcSEcCtD
Lovastatin—Alopecia—Methotrexate—colon cancer	0.000173	0.0024	CcSEcCtD
Lovastatin—Nausea—Vincristine—colon cancer	0.00017	0.00236	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00017	0.00236	CcSEcCtD
Lovastatin—Vomiting—Fluorouracil—colon cancer	0.00017	0.00236	CcSEcCtD
Lovastatin—Insomnia—Capecitabine—colon cancer	0.000169	0.00235	CcSEcCtD
Lovastatin—Rash—Fluorouracil—colon cancer	0.000168	0.00234	CcSEcCtD
Lovastatin—Dermatitis—Fluorouracil—colon cancer	0.000168	0.00234	CcSEcCtD
Lovastatin—Paraesthesia—Capecitabine—colon cancer	0.000168	0.00233	CcSEcCtD
Lovastatin—Headache—Fluorouracil—colon cancer	0.000167	0.00232	CcSEcCtD
Lovastatin—Dysgeusia—Methotrexate—colon cancer	0.000167	0.00232	CcSEcCtD
Lovastatin—Dyspnoea—Capecitabine—colon cancer	0.000166	0.00231	CcSEcCtD
Lovastatin—Nausea—Irinotecan—colon cancer	0.000166	0.0023	CcSEcCtD
Lovastatin—Back pain—Methotrexate—colon cancer	0.000165	0.00229	CcSEcCtD
Lovastatin—Dyspepsia—Capecitabine—colon cancer	0.000164	0.00228	CcSEcCtD
Lovastatin—Decreased appetite—Capecitabine—colon cancer	0.000162	0.00225	CcSEcCtD
Lovastatin—Fatigue—Capecitabine—colon cancer	0.000161	0.00224	CcSEcCtD
Lovastatin—Vision blurred—Methotrexate—colon cancer	0.00016	0.00223	CcSEcCtD
Lovastatin—Constipation—Capecitabine—colon cancer	0.00016	0.00222	CcSEcCtD
Lovastatin—Pain—Capecitabine—colon cancer	0.00016	0.00222	CcSEcCtD
Lovastatin—Nausea—Fluorouracil—colon cancer	0.000159	0.0022	CcSEcCtD
Lovastatin—Ill-defined disorder—Methotrexate—colon cancer	0.000158	0.00219	CcSEcCtD
Lovastatin—Feeling abnormal—Capecitabine—colon cancer	0.000154	0.00214	CcSEcCtD
Lovastatin—Malaise—Methotrexate—colon cancer	0.000153	0.00213	CcSEcCtD
Lovastatin—Vertigo—Methotrexate—colon cancer	0.000153	0.00212	CcSEcCtD
Lovastatin—Gastrointestinal pain—Capecitabine—colon cancer	0.000153	0.00212	CcSEcCtD
Lovastatin—Leukopenia—Methotrexate—colon cancer	0.000152	0.00212	CcSEcCtD
Lovastatin—ABCB1—liver—colon cancer	0.000152	0.0019	CbGeAlD
Lovastatin—Urticaria—Capecitabine—colon cancer	0.000148	0.00206	CcSEcCtD
Lovastatin—Abdominal pain—Capecitabine—colon cancer	0.000147	0.00205	CcSEcCtD
Lovastatin—Body temperature increased—Capecitabine—colon cancer	0.000147	0.00205	CcSEcCtD
Lovastatin—Myalgia—Methotrexate—colon cancer	0.000145	0.00201	CcSEcCtD
Lovastatin—Arthralgia—Methotrexate—colon cancer	0.000145	0.00201	CcSEcCtD
Lovastatin—Chest pain—Methotrexate—colon cancer	0.000145	0.00201	CcSEcCtD
Lovastatin—Discomfort—Methotrexate—colon cancer	0.000143	0.00199	CcSEcCtD
Lovastatin—Confusional state—Methotrexate—colon cancer	0.00014	0.00195	CcSEcCtD
Lovastatin—Anaphylactic shock—Methotrexate—colon cancer	0.000139	0.00193	CcSEcCtD
Lovastatin—Infection—Methotrexate—colon cancer	0.000138	0.00192	CcSEcCtD
Lovastatin—Hypersensitivity—Capecitabine—colon cancer	0.000137	0.00191	CcSEcCtD
Lovastatin—Thrombocytopenia—Methotrexate—colon cancer	0.000136	0.00189	CcSEcCtD
Lovastatin—Asthenia—Capecitabine—colon cancer	0.000134	0.00186	CcSEcCtD
Lovastatin—Anorexia—Methotrexate—colon cancer	0.000132	0.00184	CcSEcCtD
Lovastatin—Pruritus—Capecitabine—colon cancer	0.000132	0.00183	CcSEcCtD
Lovastatin—Diarrhoea—Capecitabine—colon cancer	0.000128	0.00177	CcSEcCtD
Lovastatin—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000127	0.00176	CcSEcCtD
Lovastatin—Insomnia—Methotrexate—colon cancer	0.000126	0.00175	CcSEcCtD
Lovastatin—Paraesthesia—Methotrexate—colon cancer	0.000125	0.00173	CcSEcCtD
Lovastatin—Dyspnoea—Methotrexate—colon cancer	0.000124	0.00172	CcSEcCtD
Lovastatin—Dizziness—Capecitabine—colon cancer	0.000123	0.00171	CcSEcCtD
Lovastatin—Dyspepsia—Methotrexate—colon cancer	0.000122	0.0017	CcSEcCtD
Lovastatin—Decreased appetite—Methotrexate—colon cancer	0.000121	0.00168	CcSEcCtD
Lovastatin—Fatigue—Methotrexate—colon cancer	0.00012	0.00166	CcSEcCtD
Lovastatin—Pain—Methotrexate—colon cancer	0.000119	0.00165	CcSEcCtD
Lovastatin—Vomiting—Capecitabine—colon cancer	0.000119	0.00165	CcSEcCtD
Lovastatin—Rash—Capecitabine—colon cancer	0.000118	0.00163	CcSEcCtD
Lovastatin—Dermatitis—Capecitabine—colon cancer	0.000118	0.00163	CcSEcCtD
Lovastatin—Headache—Capecitabine—colon cancer	0.000117	0.00162	CcSEcCtD
Lovastatin—ABCB1—lymph node—colon cancer	0.000117	0.00145	CbGeAlD
Lovastatin—Feeling abnormal—Methotrexate—colon cancer	0.000114	0.00159	CcSEcCtD
Lovastatin—Gastrointestinal pain—Methotrexate—colon cancer	0.000114	0.00158	CcSEcCtD
Lovastatin—Nausea—Capecitabine—colon cancer	0.000111	0.00154	CcSEcCtD
Lovastatin—Urticaria—Methotrexate—colon cancer	0.00011	0.00153	CcSEcCtD
Lovastatin—Abdominal pain—Methotrexate—colon cancer	0.00011	0.00153	CcSEcCtD
Lovastatin—Body temperature increased—Methotrexate—colon cancer	0.00011	0.00153	CcSEcCtD
Lovastatin—Hypersensitivity—Methotrexate—colon cancer	0.000102	0.00142	CcSEcCtD
Lovastatin—Asthenia—Methotrexate—colon cancer	9.96e-05	0.00138	CcSEcCtD
Lovastatin—Pruritus—Methotrexate—colon cancer	9.83e-05	0.00137	CcSEcCtD
Lovastatin—Diarrhoea—Methotrexate—colon cancer	9.5e-05	0.00132	CcSEcCtD
Lovastatin—Dizziness—Methotrexate—colon cancer	9.18e-05	0.00128	CcSEcCtD
Lovastatin—Vomiting—Methotrexate—colon cancer	8.83e-05	0.00123	CcSEcCtD
Lovastatin—Rash—Methotrexate—colon cancer	8.76e-05	0.00122	CcSEcCtD
Lovastatin—Dermatitis—Methotrexate—colon cancer	8.75e-05	0.00122	CcSEcCtD
Lovastatin—Headache—Methotrexate—colon cancer	8.7e-05	0.00121	CcSEcCtD
Lovastatin—Nausea—Methotrexate—colon cancer	8.25e-05	0.00115	CcSEcCtD
Lovastatin—UGT2B7—NRF2 pathway—TGFB1—colon cancer	5.61e-05	0.00094	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AXIN2—colon cancer	5.58e-05	0.000934	CbGpPWpGaD
Lovastatin—HDAC2—Direct p53 effectors—TP53—colon cancer	5.51e-05	0.000923	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ODC1—colon cancer	5.5e-05	0.000921	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CHST5—colon cancer	5.5e-05	0.000921	CbGpPWpGaD
Lovastatin—HMGCR—Integrated Breast Cancer Pathway—AKT1—colon cancer	5.48e-05	0.000917	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—colon cancer	5.46e-05	0.000915	CbGpPWpGaD
Lovastatin—HDAC2—Chromatin modifying enzymes—EP300—colon cancer	5.42e-05	0.000908	CbGpPWpGaD
Lovastatin—ITGAL—Hemostasis—AKT1—colon cancer	5.42e-05	0.000907	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—HRAS—colon cancer	5.3e-05	0.000888	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CA7—colon cancer	5.07e-05	0.00085	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—HNF4A—colon cancer	5.06e-05	0.000847	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CTNNB1—colon cancer	5.06e-05	0.000847	CbGpPWpGaD
Lovastatin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—colon cancer	5.02e-05	0.000841	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CA7—colon cancer	4.95e-05	0.00083	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—CDKN1A—colon cancer	4.94e-05	0.000827	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—CASP3—colon cancer	4.85e-05	0.000813	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PPARG—colon cancer	4.79e-05	0.000803	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—EP300—colon cancer	4.7e-05	0.000787	CbGpPWpGaD
Lovastatin—ITGAL—Adaptive Immune System—AKT1—colon cancer	4.68e-05	0.000784	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CA7—colon cancer	4.67e-05	0.000782	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CA7—colon cancer	4.63e-05	0.000775	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—SRC—colon cancer	4.57e-05	0.000765	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—CDKN1A—colon cancer	4.57e-05	0.000765	CbGpPWpGaD
Lovastatin—UGT1A1—NRF2 pathway—TGFB1—colon cancer	4.56e-05	0.000764	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—EP300—colon cancer	4.54e-05	0.000761	CbGpPWpGaD
Lovastatin—ABCC2—NRF2 pathway—TGFB1—colon cancer	4.45e-05	0.000745	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—NRAS—colon cancer	4.4e-05	0.000736	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CASP3—colon cancer	4.39e-05	0.000735	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—VEGFA—colon cancer	4.3e-05	0.00072	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—SRC—colon cancer	4.23e-05	0.000708	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—colon cancer	4.19e-05	0.000701	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—TP53—colon cancer	4.13e-05	0.000691	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—NRAS—colon cancer	4.07e-05	0.000681	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—colon cancer	4.03e-05	0.000676	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—EGFR—colon cancer	4.01e-05	0.000671	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CHST5—colon cancer	3.98e-05	0.000666	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ODC1—colon cancer	3.98e-05	0.000666	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—ABCB1—colon cancer	3.96e-05	0.000662	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—KRAS—colon cancer	3.78e-05	0.000634	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	3.77e-05	0.000632	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—VEGFA—colon cancer	3.73e-05	0.000624	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—EGFR—colon cancer	3.71e-05	0.000621	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—ABCB1—colon cancer	3.6e-05	0.000603	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—KRAS—colon cancer	3.5e-05	0.000586	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—PIK3CA—colon cancer	3.48e-05	0.000582	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ODC1—colon cancer	3.44e-05	0.000577	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CHST5—colon cancer	3.44e-05	0.000577	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TGFB1—colon cancer	3.42e-05	0.000573	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—ABCB1—colon cancer	3.38e-05	0.000566	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—PIK3CA—colon cancer	3.22e-05	0.000539	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—HRAS—colon cancer	3.22e-05	0.000539	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—EP300—colon cancer	3.14e-05	0.000525	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CHST5—colon cancer	3.07e-05	0.000515	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ODC1—colon cancer	3.07e-05	0.000515	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—APC—colon cancer	3.07e-05	0.000515	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ABCB1—colon cancer	3.07e-05	0.000514	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CA7—colon cancer	3.05e-05	0.000511	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—TYMS—colon cancer	3.01e-05	0.000505	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ODC1—colon cancer	3e-05	0.000503	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CHST5—colon cancer	3e-05	0.000503	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—HRAS—colon cancer	2.98e-05	0.000498	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.89e-05	0.000485	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—AKT1—colon cancer	2.84e-05	0.000476	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CHST5—colon cancer	2.83e-05	0.000474	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ODC1—colon cancer	2.83e-05	0.000474	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ODC1—colon cancer	2.8e-05	0.000469	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CHST5—colon cancer	2.8e-05	0.000469	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—EP300—colon cancer	2.75e-05	0.000461	CbGpPWpGaD
Lovastatin—ABCB1—HIF-1-alpha transcription factor network—AKT1—colon cancer	2.74e-05	0.00046	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—SRC—colon cancer	2.68e-05	0.000449	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—AKT1—colon cancer	2.63e-05	0.00044	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—VEGFA—colon cancer	2.61e-05	0.000437	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—NRAS—colon cancer	2.58e-05	0.000432	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ABCB1—colon cancer	2.5e-05	0.000419	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—colon cancer	2.47e-05	0.000414	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—TYMS—colon cancer	2.46e-05	0.000412	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TGFB1—colon cancer	2.39e-05	0.000401	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—colon cancer	2.33e-05	0.000391	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	2.32e-05	0.000389	CbGpPWpGaD
Lovastatin—HDAC2—Disease—FGFR3—colon cancer	2.3e-05	0.000385	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	2.28e-05	0.000381	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—KRAS—colon cancer	2.22e-05	0.000371	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—PPARG—colon cancer	2.2e-05	0.000368	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—colon cancer	2.17e-05	0.000363	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PPARG—colon cancer	2.14e-05	0.000358	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ABCB1—colon cancer	2.13e-05	0.000356	CbGpPWpGaD
Lovastatin—HDAC2—Disease—APC—colon cancer	2.11e-05	0.000354	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—colon cancer	2.11e-05	0.000353	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—TYMS—colon cancer	2.09e-05	0.00035	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—colon cancer	2.09e-05	0.00035	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—colon cancer	2.04e-05	0.000342	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—PIK3CA—colon cancer	2.04e-05	0.000341	CbGpPWpGaD
Lovastatin—HDAC2—Disease—BRAF—colon cancer	1.99e-05	0.000332	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—TP53—colon cancer	1.97e-05	0.00033	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.95e-05	0.000326	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—colon cancer	1.94e-05	0.000325	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.89e-05	0.000317	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—colon cancer	1.89e-05	0.000316	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—HRAS—colon cancer	1.89e-05	0.000316	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ABCB1—colon cancer	1.85e-05	0.00031	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CHST5—colon cancer	1.85e-05	0.00031	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ODC1—colon cancer	1.85e-05	0.00031	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—colon cancer	1.84e-05	0.000308	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—TYMS—colon cancer	1.82e-05	0.000305	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PPARG—colon cancer	1.74e-05	0.000292	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ABCB1—colon cancer	1.73e-05	0.00029	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—TYMS—colon cancer	1.7e-05	0.000284	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—colon cancer	1.69e-05	0.000283	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—colon cancer	1.69e-05	0.000283	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PTGS2—colon cancer	1.68e-05	0.000281	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—AKT1—colon cancer	1.66e-05	0.000279	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—colon cancer	1.65e-05	0.000277	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—colon cancer	1.62e-05	0.000271	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—FGFR3—colon cancer	1.61e-05	0.00027	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PTGS2—colon cancer	1.6e-05	0.000269	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ABCB1—colon cancer	1.58e-05	0.000265	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—colon cancer	1.56e-05	0.000262	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—TYMS—colon cancer	1.56e-05	0.000261	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PPARG—colon cancer	1.48e-05	0.000248	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—APC—colon cancer	1.48e-05	0.000248	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ABCB1—colon cancer	1.45e-05	0.000243	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—colon cancer	1.44e-05	0.00024	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CTNNB1—colon cancer	1.43e-05	0.00024	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—TYMS—colon cancer	1.43e-05	0.000239	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.42e-05	0.000238	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CDKN1A—colon cancer	1.4e-05	0.000235	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.4e-05	0.000235	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—EP300—colon cancer	1.4e-05	0.000234	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—BRAF—colon cancer	1.39e-05	0.000233	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—colon cancer	1.39e-05	0.000233	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PTGS2—colon cancer	1.37e-05	0.000229	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EP300—colon cancer	1.33e-05	0.000223	CbGpPWpGaD
Lovastatin—HDAC2—Disease—SRC—colon cancer	1.3e-05	0.000217	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PPARG—colon cancer	1.29e-05	0.000216	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.27e-05	0.000213	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—MYC—colon cancer	1.25e-05	0.00021	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NRAS—colon cancer	1.25e-05	0.000209	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PPARG—colon cancer	1.2e-05	0.000201	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	1.2e-05	0.000201	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—colon cancer	1.17e-05	0.000196	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PTGS2—colon cancer	1.16e-05	0.000195	CbGpPWpGaD
Lovastatin—HDAC2—Disease—MYC—colon cancer	1.16e-05	0.000195	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TGFB1—colon cancer	1.16e-05	0.000194	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—colon cancer	1.16e-05	0.000194	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—EP300—colon cancer	1.14e-05	0.000191	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EGFR—colon cancer	1.14e-05	0.00019	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	1.12e-05	0.000187	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PPARG—colon cancer	1.1e-05	0.000185	CbGpPWpGaD
Lovastatin—HDAC2—Disease—KRAS—colon cancer	1.07e-05	0.00018	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ABCB1—colon cancer	1.05e-05	0.000176	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CASP3—colon cancer	1.04e-05	0.000175	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—PIK3CA—colon cancer	1.03e-05	0.000173	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—TYMS—colon cancer	1.03e-05	0.000173	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCND1—colon cancer	1.01e-05	0.00017	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PTGS2—colon cancer	1.01e-05	0.00017	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PPARG—colon cancer	1.01e-05	0.000169	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CTNNB1—colon cancer	1e-05	0.000168	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.98e-06	0.000167	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PIK3CA—colon cancer	9.87e-06	0.000165	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CDKN1A—colon cancer	9.81e-06	0.000164	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—EP300—colon cancer	9.68e-06	0.000162	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PTGS2—colon cancer	9.46e-06	0.000158	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EP300—colon cancer	9.34e-06	0.000156	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—EP300—colon cancer	9.3e-06	0.000156	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HRAS—colon cancer	9.13e-06	0.000153	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—colon cancer	9.1e-06	0.000152	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ABCB1—colon cancer	9.1e-06	0.000152	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SRC—colon cancer	9.08e-06	0.000152	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—TYMS—colon cancer	8.94e-06	0.00015	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VEGFA—colon cancer	8.84e-06	0.000148	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NRAS—colon cancer	8.74e-06	0.000146	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—AKT1—colon cancer	8.68e-06	0.000145	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PTGS2—colon cancer	8.67e-06	0.000145	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—AKT1—colon cancer	8.44e-06	0.000141	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—EP300—colon cancer	8.43e-06	0.000141	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—PIK3CA—colon cancer	8.42e-06	0.000141	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—EP300—colon cancer	8.3e-06	0.000139	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—MYC—colon cancer	8.14e-06	0.000136	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ABCB1—colon cancer	8.12e-06	0.000136	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TGFB1—colon cancer	8.12e-06	0.000136	CbGpPWpGaD
Lovastatin—HDAC2—Disease—AKT1—colon cancer	8.06e-06	0.000135	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—TYMS—colon cancer	7.98e-06	0.000134	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGFR—colon cancer	7.96e-06	0.000133	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PTGS2—colon cancer	7.96e-06	0.000133	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—EP300—colon cancer	7.87e-06	0.000132	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—TYMS—colon cancer	7.79e-06	0.00013	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—colon cancer	7.57e-06	0.000127	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—KRAS—colon cancer	7.52e-06	0.000126	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ABCB1—colon cancer	7.47e-06	0.000125	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ABCB1—colon cancer	7.41e-06	0.000124	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—TYMS—colon cancer	7.34e-06	0.000123	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PPARG—colon cancer	7.31e-06	0.000122	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—TYMS—colon cancer	7.28e-06	0.000122	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—EP300—colon cancer	7.21e-06	0.000121	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—PIK3CA—colon cancer	7.16e-06	0.00012	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PIK3CA—colon cancer	6.91e-06	0.000116	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.88e-06	0.000115	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—AKT1—colon cancer	6.88e-06	0.000115	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TP53—colon cancer	6.68e-06	0.000112	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—EP300—colon cancer	6.62e-06	0.000111	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—HRAS—colon cancer	6.39e-06	0.000107	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PPARG—colon cancer	6.33e-06	0.000106	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—PIK3CA—colon cancer	6.24e-06	0.000104	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	6.14e-06	0.000103	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—AKT1—colon cancer	5.85e-06	9.8e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—PIK3CA—colon cancer	5.82e-06	9.75e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PTGS2—colon cancer	5.75e-06	9.63e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PPARG—colon cancer	5.65e-06	9.47e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—AKT1—colon cancer	5.64e-06	9.45e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—colon cancer	5.6e-06	9.38e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PPARG—colon cancer	5.52e-06	9.24e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—PIK3CA—colon cancer	5.33e-06	8.93e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PPARG—colon cancer	5.2e-06	8.71e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PPARG—colon cancer	5.15e-06	8.63e-05	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—AKT1—colon cancer	5.1e-06	8.53e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PTGS2—colon cancer	4.98e-06	8.34e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—PIK3CA—colon cancer	4.9e-06	8.2e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCB1—colon cancer	4.89e-06	8.18e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—TYMS—colon cancer	4.8e-06	8.04e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—EP300—colon cancer	4.78e-06	8.01e-05	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—AKT1—colon cancer	4.76e-06	7.96e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PTGS2—colon cancer	4.45e-06	7.45e-05	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—AKT1—colon cancer	4.36e-06	7.3e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PTGS2—colon cancer	4.34e-06	7.27e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—EP300—colon cancer	4.14e-06	6.94e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PTGS2—colon cancer	4.09e-06	6.85e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PTGS2—colon cancer	4.05e-06	6.79e-05	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—AKT1—colon cancer	4e-06	6.7e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—EP300—colon cancer	3.7e-06	6.19e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—EP300—colon cancer	3.61e-06	6.05e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—PIK3CA—colon cancer	3.54e-06	5.93e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—EP300—colon cancer	3.4e-06	5.7e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PPARG—colon cancer	3.4e-06	5.69e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—EP300—colon cancer	3.37e-06	5.65e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—PIK3CA—colon cancer	3.07e-06	5.13e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—AKT1—colon cancer	2.89e-06	4.84e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—PIK3CA—colon cancer	2.74e-06	4.58e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PTGS2—colon cancer	2.67e-06	4.48e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—PIK3CA—colon cancer	2.67e-06	4.47e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—PIK3CA—colon cancer	2.52e-06	4.21e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—AKT1—colon cancer	2.5e-06	4.19e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—PIK3CA—colon cancer	2.49e-06	4.18e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—AKT1—colon cancer	2.23e-06	3.74e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—EP300—colon cancer	2.22e-06	3.72e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—AKT1—colon cancer	2.18e-06	3.65e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—AKT1—colon cancer	2.06e-06	3.44e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—AKT1—colon cancer	2.04e-06	3.41e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—PIK3CA—colon cancer	1.65e-06	2.76e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—AKT1—colon cancer	1.34e-06	2.25e-05	CbGpPWpGaD
